Administration of a Xuebijing injection can suppress the production and release of high mobility group box-1 protein (HMGB1) in the kidney, thereby alleviating serious scald injury-induced AKI (Wang et al., 2007). The gene discussed is HMGB1; the disease is acute kidney injury.